NCT00853034

CompletedPhase 4

Effects of Arabinoxylan-Oligosaccharides Compared to Other P...

KU Leuven Source

Compare

Other study identifiers

Sponsor study identifier

AXOS 001

Study Type

interventional

Actual enrollment (reported)

20

Locations

1 country

Sites

1

Timeline

Study Start

October 2006

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

Not reported

Date not reported

Study Completion

September 2007

Actual (reported)

Brief Summary

The purpose of the study is to evaluate the effects of arabinoxylan-oligosaccharides (AXOS) on the colonic metabolism and microbial composition, and to compare these effects with the reference prebiotic fructo-oligosaccharide enriched inulin.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 20 participants
Study completion date: September 2007
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Some registry-reported names shown below are not yet linked in this graph.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
October 2006
Date type not reported
This date has not been verified as actual or estimated.
Study Completion
September 2007
Actual (reported)
First Submitted
February 25, 2009
Actual (reported)
First Posted
February 27, 2009
Actual (reported)

Last Updated: February 27, 2009
Status Verified: February 2009
Last Update Submitted: February 26, 2009

Conditions

Healthy

Keywords

gastrointestinal effectsprebiotic

Study Arms (2)

FOS-IN

ACTIVE COMPARATOR

prebiotic fructo-oligosaccharide enriched inulin

Dietary Supplement: FOS-IN

AXOS

EXPERIMENTAL

arabinoxylan-oligosaccharides (AXOS)

Dietary Supplement: AXOS

Interventions

FOS-INDietary supplement

prebiotic fructo-oligosaccharide enriched inulin intake period: 2 weeks, 1.25 or 2.50g every morning and evening

Also known as: Synergy1, Orafti, Tienen

FOS-IN

AXOSDietary supplement

arabinoxylan-oligosaccharides (AXOS) intake period: 2 weeks, 1.25 or 2.50g every morning and evening

Eligibility Criteria

Age18 Years - 45 Years

Sexall

Healthy VolunteersYes

Age GroupsAdult (18-64)

You may qualify if:

healthy
years

Sponsors & Collaborators

KU Leuven
Otherlead

Study Sites (1)

Department of Gastrointestinal Research, Laboratory Digestion and Absorption

Leuven, Leuven, 3000, Belgium

Related Publications (1)

Cloetens L, De Preter V, Swennen K, Broekaert WF, Courtin CM, Delcour JA, Rutgeerts P, Verbeke K. Dose-response effect of arabinoxylooligosaccharides on gastrointestinal motility and on colonic bacterial metabolism in healthy volunteers. J Am Coll Nutr. 2008 Aug;27(4):512-8. doi: 10.1080/07315724.2008.10719733.
PMID: 18978172BACKGROUND

Study Officials

Kristin Verbeke, PhD
KU Leuven
STUDY DIRECTOR

Enrollment

20 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: phase 4
Allocation: RANDOMIZED
Masking: SINGLE
Who Masked: PARTICIPANT
Purpose: TREATMENT
Intervention Model: CROSSOVER
Sponsor Type: OTHER

Study Record Dates

First Submitted

February 25, 2009

First Posted

February 27, 2009

Study Start

October 2006

Date type not reported

This date has not been verified as actual or estimated.

NCT00397059

Pupillary Changes as a Potential Biomarker for Escitalopram in Relation to CYP2C19 Polymorphism

Phase 4Completed

NCT00408941

EEG and Auditory Evoked Potentials During Local Anesthesia

Phase 4Unknown

NCT00338910

Pharmacokinetic Interaction Study Between Budesonide and Metronidazole in Healthy Volunteers

Phase 4Completed

NCT00321360

Effect Site Controlled, Reaction Time Safeguarded, Patient Maintained Sedation With Propofol in Healthy Volunteers

Phase 4Completed

NCT00311974

The Effect of Dihydralazine on Kidney Function and Hormones in Healthy Individuals

Phase 4Completed

NCT00504894

Neuroimaging the Effects of Intravenous Anesthetic on Amygdala Dependent Memory Processes

Phase 4Terminated

AXOS

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

regular eating pattern

You may not qualify if:

gastrointestinal complaints
antibiotic intake
medication influencing gut transit or microbiota
abdominal surgery
pregnancy

Contact the study team to confirm eligibility.

Study Completion

September 2007

Actual (reported)

Last Updated

February 27, 2009

Record last verified: 2009-02

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT00853034
Data provider: ClinicalTrials.gov
Source updated: 2009-02-27
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:36:51 UTC

Locations

BE(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Study Completion

First Submitted

First Posted

Conditions

Keywords

Study Arms (2)

FOS-IN

AXOS

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

Related Publications (1)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations